Bullish Moving Averages
14
Bearish Moving Averages
2
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
336.00Today’s High
346.7052W low
250.1052W High
356.70Open Price
345.20Prev. Close
286.1500Volume
323199.00Value
108853423.20Fundamentals
Market Cap Cr
4152.80
Price to Earnings
59.70
Price to Book Value
3.50
Dividend Yield
0.40
PE to Growth
-5.30
Op Revenue TTM Cr
1784.60
Net Profit TTM Cr
69.60
Cash From Operating Activity Cr
186.72
Return on Equity %
5.86
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
52.7
Week
41.9
Month
36.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
339.83
PIVOT
First Resistance
343.67
Second Resistance
350.53
Third Resistance
354.37
First Support
332.97
Second Support
329.13
Third Support
322.27
Relative Strength Index
62.36
Money Flow Index
85.46
MACD
12.86
MACD Signal
10.11
Average True Range
13
Average Directional Index
21.38
Rate of Change (21)
18.24
Rate of Change (125)
12.19
Commodity Channel Index
83.2
Williams %R
-31.9
BETA
1 Month
0.62
3 Month
0.68
1 Year
0.55
3 Year
0.23
PRICE CHANGE ANALYSIS
↓ -0.36%
1 Week
Low
High
321.1
354.15
↑ 18.24%
1 Month
Low
High
267.25
356.7
↑ 16.68%
3 Months
Low
High
267.25
356.7
↑ 9.44%
6 Months
Low
High
260.3
356.7
↑ 8.04%
1 Year
Low
High
250.1
356.7
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 514.56 | 447.63 | 435.87 | 388.99 | 545.67 | 542.71 | 560.00 | 382.06 | 502.62 | 515.10 | 469.93 | |
| Operating Expenses Qtr | 419.75 | 382.68 | 377.41 | 337.82 | 457.21 | 465.62 | 489.02 | 356.12 | 441.31 | 421.62 | 378.17 | |
| Operating Profit Qtr | 94.35 | 64.89 | 57.47 | 50.23 | 88.08 | 74.58 | 69.73 | 22.67 | 61.04 | 92.91 | 90.89 | |
| EBIDT Qtr Cr | 94.81 | 64.95 | 58.46 | 51.17 | 88.46 | 77.09 | 70.98 | 25.94 | 61.31 | 93.48 | 91.76 | |
| Depreciation Qtr | 32.34 | 28.97 | 28.57 | 27.73 | 26.83 | 28.27 | 27.41 | 26.50 | 24.23 | 24.68 | 24.20 | |
| Net Profit Qtr | 33.86 | 16.27 | 12.52 | 6.86 | 36.07 | 26.41 | 24.84 | -8.94 | 20.76 | 45.20 | 44.05 | |
| Basic EPS Qtr | 2.75 | 1.32 | 1.02 | 0.56 | 2.93 | 2.14 | 2.01 | -0.73 | 1.68 | 3.67 | 3.57 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1787.05 | 2028.44 | 1947.61 | 1725.42 | 1510.96 | |
| Operating Expenses Annual Cr | 1517.66 | 1765.97 | 1602.15 | 1397.55 | 1234.10 | |
| Operating Profit Annual | 266.94 | 257.06 | 340.57 | 322.89 | 273.16 | |
| Operating Profit Margin Annual % | 14.94 | 12.67 | 17.49 | 18.71 | 18.08 | |
| Total Expenses Annual Cr | 1691.64 | 1923.08 | 1729.04 | 1518.99 | 1368.98 | |
| EBIDT Annual Cr | 269.39 | 262.47 | 345.46 | 327.87 | 276.86 | |
| EBIDT Annual margin % | 15.07 | 12.94 | 17.74 | 19.00 | 18.32 | |
| Depreciation | 117.61 | 109.01 | 95.67 | 85.25 | 82.46 | |
| PAT Before ExtraOrdinary Items Annual Cr | 69.51 | 78.38 | 160.51 | 133.14 | 84.44 | |
| Net Profit Annual | 69.51 | 78.38 | 160.51 | 133.14 | 84.44 | |
| Basic EPS Annual | 5.64 | 6.36 | 13.02 | 10.80 | 6.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1187.59 | 1133.49 | 1068.01 | 933.42 | 816.52 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 542.85 | 590.46 | 375.94 | 323.03 | 355.16 | |
| Total Current Liabilities Annual Cr | 756.62 | 661.53 | 769.17 | 656.78 | 596.32 | |
| Total Capital Plus Liabilities Annual Cr | 2487.06 | 2385.48 | 2213.12 | 1913.23 | 1767.99 | |
| Fixed Assets Annual | 1484.97 | 1360.46 | 1174.25 | 966.79 | 896.04 | |
| Total Non Current Assets Annual | 1520.54 | 1446.47 | 1248.84 | 1034.63 | 993.23 | |
| Total Current Assets Annual | 966.52 | 939.00 | 964.28 | 878.60 | 774.76 | |
| Total Assets Annual | 2487.06 | 2385.48 | 2213.12 | 1913.23 | 1767.99 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 225.15 | 148.28 | 145.59 | 111.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 186.63 | 315.29 | 293.73 | 229.02 | 284.93 | |
| Cash from Investing Activity Annual | -173.75 | -292.34 | -284.37 | -156.20 | -163.80 | |
| Cash from Financing Annual Activity | -27.00 | -7.68 | -5.56 | -96.87 | -100.86 | |
| Net Cash Flow Annual | - | 15.27 | 3.80 | -24.05 | 20.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 96.32 | 91.93 | 86.62 | 75.70 | 66.22 | |
| ROE Annual % | 5.85 | 6.91 | 15.02 | 14.26 | 10.34 | |
| ROCE Annual % | 8.77 | 8.90 | 17.29 | 19.31 | 16.59 | |
| Total Debt to Total Equity Annual | 0.69 | 0.66 | 0.63 | 0.55 | 0.69 | |
| EBDIT Annual Margin % | 15.09 | 12.97 | 17.78 | 19.05 | 18.36 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 514.56 | 447.63 | 435.87 | 388.99 | 545.67 | 542.71 | 560.00 | 382.06 | 502.62 | 515.10 | 469.93 | |
| Operating Expenses Qtr | 419.64 | 382.81 | 377.36 | 337.76 | 457.28 | 465.62 | 489.02 | 356.04 | 441.36 | 421.62 | 378.16 | |
| Operating Profit Qtr | 94.46 | 64.76 | 57.52 | 50.29 | 88.01 | 74.58 | 69.73 | 22.75 | 60.99 | 92.91 | 90.90 | |
| EBIDT Qtr Cr | 94.92 | 64.82 | 58.51 | 51.23 | 88.39 | 77.09 | 70.98 | 26.02 | 61.26 | 93.48 | 91.77 | |
| Depreciation Qtr | 32.34 | 28.97 | 28.57 | 27.73 | 26.83 | 28.27 | 27.41 | 26.50 | 24.23 | 24.68 | 24.20 | |
| Net Profit Qtr | 33.97 | 16.14 | 12.57 | 6.92 | 36.00 | 26.41 | 24.84 | -8.86 | 20.71 | 45.20 | 44.06 | |
| Basic EPS Qtr | 2.76 | 1.31 | 1.02 | 0.56 | 2.92 | 2.14 | 2.01 | -0.72 | 1.68 | 3.67 | 3.57 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1787.05 | 2028.44 | 1947.61 | 1725.42 | 1510.96 | |
| Operating Expenses Annual Cr | 1517.57 | 1765.96 | 1602.16 | 1397.55 | 1234.11 | |
| Operating Profit Annual | 267.03 | 257.07 | 340.56 | 322.89 | 273.16 | |
| Operating Profit Margin Annual % | 14.94 | 12.67 | 17.49 | 18.71 | 18.08 | |
| Total Expenses Annual Cr | 1691.55 | 1923.08 | 1729.05 | 1518.99 | 1368.98 | |
| EBIDT Annual Cr | 269.48 | 262.48 | 345.45 | 327.87 | 276.86 | |
| EBIDT Annual margin % | 15.08 | 12.94 | 17.74 | 19.00 | 18.32 | |
| Depreciation | 117.61 | 109.01 | 95.67 | 85.25 | 82.46 | |
| PAT Before ExtraOrdinary Items Annual Cr | 69.60 | 78.38 | 160.50 | 133.14 | 84.44 | |
| Net Profit Annual | 69.60 | 78.38 | 160.50 | 133.14 | 84.44 | |
| Basic EPS Annual | 5.64 | 6.36 | 13.02 | 10.80 | 6.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 1187.66 | 1133.47 | 1067.98 | 933.40 | 816.50 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 542.85 | 590.46 | 375.94 | 323.03 | 355.16 | |
| Total Current Liabilities Annual Cr | 756.63 | 661.55 | 769.18 | 656.78 | 596.32 | |
| Total Capital Plus Liabilities Annual Cr | 2487.14 | 2385.48 | 2213.11 | 1913.22 | 1767.98 | |
| Fixed Assets Annual | 1484.97 | 1360.46 | 1174.25 | 966.79 | 896.04 | |
| Total Non Current Assets Annual | 1520.53 | 1446.46 | 1248.83 | 1034.62 | 993.22 | |
| Total Current Assets Annual | 966.61 | 939.02 | 964.28 | 878.60 | 774.76 | |
| Total Assets Annual | 2487.14 | 2385.48 | 2213.11 | 1913.22 | 1767.98 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 225.15 | 148.28 | 145.60 | 111.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 186.72 | 315.31 | 293.73 | 229.02 | 284.93 | |
| Cash from Investing Activity Annual | -173.75 | -292.34 | -284.37 | -156.20 | -163.80 | |
| Cash from Financing Annual Activity | -27.00 | -7.68 | -5.56 | -96.87 | -100.86 | |
| Net Cash Flow Annual | - | 15.29 | 3.80 | -24.05 | 20.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 96.32 | 91.93 | 86.62 | 75.70 | 66.22 | |
| ROE Annual % | 5.86 | 6.91 | 15.02 | 14.26 | 10.34 | |
| ROCE Annual % | 8.77 | 8.90 | 17.29 | 19.31 | 16.59 | |
| Total Debt to Total Equity Annual | 0.69 | 0.66 | 0.63 | 0.55 | 0.69 | |
| EBDIT Annual Margin % | 15.10 | 12.97 | 17.78 | 19.05 | 18.36 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Government Pension Fund Global | 2.71 | 74543333 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SUGANDHA JAI HIREMATH | 7.84 | 74543303 | 0 | 0 |
| JAI V HIREMATH | 1.09 | 74543304 | 0 | 0 |
| KALYANI INVESTMENT COMPANY LIMITED | 31.36 | 74543311 | 0 | 0 |
| SHRI BADRINATH INVESTMENT PVT LTD | 16.15 | 74543312 | 0 | 0 |
| SHRI RAMESHWARA INVESTMENT PVT LTD | 7.96 | 74543313 | 0 | 0 |
| BF INVESTMENT LIMITED | 2.65 | 74543314 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Tata Mutual Fund - Tata Small Cap Fund | 2.68 | 74543329 |
| Government Pension Fund Global | 2.71 | 74543333 |
| Theleme India Master Fund Limited | 1.64 | 74543334 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 0.75 | 74543337 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 20, 2024 | 0.6 | INTERIM | Feb 20, 2024 | Equity Share |
| Sep 18, 2023 | 0.6 | FINAL | - | Equity Share |
| Feb 14, 2023 | 0.6 | INTERIM | Feb 14, 2023 | Equity Share |
| Sep 14, 2022 | 0.4 | FINAL | Sep 15, 2022 | Equity Share |
| Feb 23, 2022 | 1.2 | INTERIM | Feb 24, 2022 | Equity Share |
| Aug 25, 2021 | 1 | FINAL | Aug 26, 2021 | Equity Share |
| Feb 15, 2021 | 1 | INTERIM | Feb 16, 2021 | Equity Share |
| Sep 07, 2020 | 0.2 | FINAL | - | Equity Share |
| Feb 17, 2020 | 1 | INTERIM | Feb 18, 2020 | Equity Share |
| Jul 23, 2019 | 0.6 | FINAL | - | Equity Share |
| Feb 13, 2019 | 0.6 | INTERIM | Feb 14, 2019 | Equity Share |
| Jul 31, 2018 | 0.5 | FINAL | - | Equity Share |
| Feb 21, 2018 | 0.7 | INTERIM | Feb 22, 2018 | Equity Share |
| Aug 02, 2017 | 0.6 | FINAL | - | Equity Share |
| Feb 13, 2017 | 0.6 | INTERIM | Feb 14, 2017 | Equity Share |
| Aug 02, 2016 | 0.5 | FINAL | - | Equity Share |
| May 17, 2016 | 0.5 | INTERIM | May 18, 2016 | Equity Share |
| Aug 04, 2015 | 0.5 | FINAL | - | Equity Share |
| May 18, 2015 | 0.5 | INTERIM | May 19, 2015 | Equity Share |
| Aug 14, 2014 | 2.5 | FINAL | - | Equity Share |
| Feb 18, 2014 | 2 | INTERIM | Feb 20, 2014 | Equity Share |
| Aug 13, 2013 | 2.5 | FINAL | - | Equity Share |
| Aug 14, 2012 | 6 | FINAL | - | Equity Share |
| Aug 09, 2011 | 3 | FINAL | - | Equity Share |
| May 24, 2011 | 3 | INTERIM | May 25, 2011 | Equity Share |
| Aug 09, 2010 | 4 | FINAL | - | Equity Share |
| May 11, 2010 | 4 | INTERIM | May 12, 2010 | Equity Share |
| Aug 11, 2008 | 4 | FINAL | - | Equity Share |
| Jan 31, 2008 | 3 | INTERIM | Feb 01, 2008 | Equity Share |
| Aug 13, 2007 | 3.5 | FINAL | - | Equity Share |
| Feb 14, 2007 | 3 | INTERIM | Feb 15, 2007 | Equity Share |
| Aug 11, 2006 | 3.5 | FINAL | - | Equity Share |
| Feb 03, 2006 | 3 | INTERIM | Feb 06, 2006 | Equity Share |
| Aug 16, 2005 | 3.5 | FINAL | - | Equity Share |
| Feb 08, 2005 | 3 | INTERIM | Feb 09, 2005 | Equity Share |
| Aug 03, 2004 | 3 | FINAL | - | Equity Share |
| Jan 29, 2004 | 2 | INTERIM | Jan 30, 2004 | Equity Share |
| Aug 12, 2003 | 2.5 | FINAL | - | Equity Share |
| Jun 04, 2003 | 4 | INTERIM | Jun 05, 2003 | Equity Share |
| Jul 11, 2002 | 4.5 | INTERIM | - | Equity Share |
| Nov 02, 2001 | - | INTERIM | Nov 17, 2001 | Equity Share |
| Jun 25, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Feb 27, 2015 | 10:2 | - |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 09, 2024 | Audited Results & Final Dividend | - |
| Feb 08, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 02, 2023 | Quarterly Results | - |
| Aug 08, 2023 | Quarterly Results | - |
| May 29, 2023 | Audited Results & Final Dividend | - |
| Feb 02, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 09, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 28, 2022 | Audited Results & Final Dividend | - |
| Feb 14, 2022 | Quarterly Results & Interim Dividend | - |
| Oct 26, 2021 | Quarterly Results | - |
| Aug 05, 2021 | Quarterly Results | - |
| May 06, 2021 | Audited Results & Final Dividend | - |
| Feb 04, 2021 | Quarterly Results & Interim Dividend | - |
| Nov 04, 2020 | Quarterly Results | - |
| Aug 04, 2020 | Quarterly Results | - |
| Jun 18, 2020 | Audited Results & Final Dividend | - |
| Feb 05, 2020 | Quarterly Results & Interim Dividend | - |
| Oct 25, 2019 | Quarterly Results | - |
| Aug 01, 2019 | Quarterly Results | - |
| May 09, 2019 | Audited Results & Final Dividend | - |
| Feb 01, 2019 | Quarterly Results & Interim Dividend | - |
| Nov 01, 2018 | Quarterly Results | - |
| Aug 08, 2018 | Unaudited Financial Results | - |
| May 09, 2018 | Audited Results, F. Dividend & Bonus | - |
| Feb 08, 2018 | Quarterly Results & Interim Dividend | - |
| Nov 01, 2017 | Quarterly Results | - |
| Aug 10, 2017 | Quarterly Results | - |
| May 10, 2017 | Audited Results & Dividend | - |
| Feb 01, 2017 | Quarterly Results & Interim Dividend | - |
| Nov 09, 2016 | Quarterly Results | - |
| Aug 10, 2016 | Quarterly Results | - |
| May 06, 2016 | Audited Results & Final Dividend | Interim Dividend |
| Feb 03, 2016 | Quarterly Results | - |
| Oct 28, 2015 | Quarterly Results | - |
| Jul 29, 2015 | Quarterly Results | - |
| May 05, 2015 | Audited Results & Dividend | - |
| Jan 29, 2015 | Quarterly Results | - |
| Dec 17, 2014 | Stock Split | To discuss on sub division of equity shares of the Company. |
| Nov 05, 2014 | Quarterly Results | - |
| Aug 07, 2014 | Quarterly Results | - |
| May 06, 2014 | Audited Results & Dividend | - |
| Feb 06, 2014 | Quarterly Results & Dividend | - |
| Oct 28, 2013 | Quarterly Results | - |
| Aug 07, 2013 | Quarterly Results | - |
| May 16, 2013 | Audited Results & Dividend | - |
| Feb 06, 2013 | Quarterly Results | - |
| Nov 06, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| May 14, 2012 | Audited Results & Dividend | - |
| Feb 09, 2012 | Quarterly Results | - |
| Nov 10, 2011 | Quarterly Results | - |
| Jul 28, 2011 | Quarterly Results | - |
| May 12, 2011 | Aud. Results, Dividend & Intm. Dividend | - |
| Feb 08, 2011 | Quarterly Results | - |
| Nov 11, 2010 | Quarterly Results | - |
| Jul 22, 2010 | Quarterly Results | - |
| Apr 30, 2010 | Audited Results & Dividend | - |
| Jan 23, 2010 | Quarterly Results | - |
| Oct 22, 2009 | Quarterly Results | - |
| Jul 23, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results | - |
| Mar 25, 2009 | To consider Scheme of Arrangement | To consider a proposal for merger of Hikal Pharmaceuticals Ltd, a WoS of the Co., with itself pursuant to a SoA & the entire equity share capital of Hikal Pharma will stand automatically cancelled. |
| Jan 20, 2009 | Quarterly Results & Interim Dividend | Inter alia, decision regarding declaration of Interim Dividend is deferred. |
| Oct 22, 2008 | Quarterly Results | - |
| Jul 17, 2008 | Quarterly Results | - |
| Jul 03, 2008 | Audited Results, F. Dividend & Others | To issue upto 13,60,000 Equity shares of Rs 10/- each on preferential basis to International Finance Corporation (IFC) by investing upto Rs 64.46 crores, in compliance with SEBI Guidelines. |
| Apr 28, 2008 | Quarterly Results | - |
| Jan 17, 2008 | Quarterly Results & Interim Dividend | - |
| Oct 18, 2007 | Quarterly Results | - |
| Jul 26, 2007 | Quarterly Results | - |
| Jul 05, 2007 | Audited Results & Final Dividend | - |
| Apr 25, 2007 | Quarterly Results | - |
| Jan 30, 2007 | Quarterly & Interim Dividend | - |
| Oct 31, 2006 | Quarterly Results | - |
| Jul 31, 2006 | Quarterly Results | - |
| May 18, 2006 | Accounts & Dividend | - |
| Jan 19, 2006 | Quarterly Results & Interim Dividend | - |
| Nov 24, 2005 | Allotment of 7% CRPS | Has decided to allot 4,698,225 - 7% Cumulative Redeemable Preference Shares (CRPS) of Rs 100/- each aggregating Rs 46.982 million for cash at par. |
| Oct 20, 2005 | Quarterly Results | - |
| Oct 06, 2005 | Increase in the share capital & Others | Issue of 47,00,000 Convertible Cumulative Redeemable Preference Shares of Rs 100 each at par. |
| Jul 28, 2005 | Quarterly Results | - |
| May 19, 2005 | Accounts, Dividend & Others | To consider various option of raising capital through further issue of securities. |
| Jan 24, 2005 | Quarterly Results & Interim Dividend | (Purpose Revised) |
| Oct 21, 2004 | Quarterly Results | - |
| Jul 15, 2004 | Quarterly Results | - |
| May 13, 2004 | Dividend & Accounts | - |
| Apr 29, 2004 | Quarterly Results | - |
| Jan 13, 2004 | Interim Dividend | - |
| Oct 16, 2003 | Quarterly Results | - |
| Jul 14, 2003 | Bonus issue | - |
| May 06, 2003 | Dividend & Accounts | - |
| Jan 17, 2003 | Quarterly Results | - |
| Oct 31, 2002 | Quarterly Results | - |
| Jul 23, 2002 | Quarterly Results | - |
| Apr 25, 2002 | Dividend & Accounts | - |
| Mar 09, 2002 | Interim Dividend | - |
| Jan 11, 2002 | Quarterly Results | - |
| Oct 23, 2001 | Quarterly Results & Interim Dividend | - |
| Jul 16, 2001 | Quarterly Results | - |
| May 15, 2001 | Dividend & accounts | - |
| May 07, 2001 | Dividend & Accounts | - |
| Jan 12, 2001 | Quarterly Results & Dividend | Interim Dividend |
| Oct 23, 2000 | Quarterly Results | - |
| Oct 04, 2000 | Others | Allotment of Bonus shares |
| May 12, 2000 | Accounts | - |
| Jan 25, 2000 | Quarterly Results | - |
| Oct 29, 1999 | Quarterly Results | - |
| Jul 31, 1999 | Quarterly Results | - |
| May 26, 1999 | Accounts | - |
| Jan 27, 1999 | Quarterly Results | - |
| Oct 31, 1998 | Quarterly Results | - |
| Oct 18, 1997 | Half Yearly Results. | - |
| Aug 13, 1997 | Accounts, Dividend & Pvt. Placements | - |
| May 23, 1997 | Half Yearly Results. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jun 22, 2018 | 1:2 | 2018-06-25 |
| Sep 29, 2003 | 1:2 | 2003-10-01 |
| Aug 23, 2000 | 1:1 | - |
26 Jun 2024
HIKAL LTD. - 524735 - Closure of Trading Window
Intimation of closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
06 Jun 2024
HIKAL LTD. - 524735 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation under Regulation 30 of SEBI Listing Regulations - Reminder letters to shareholders regarding unclaimed Final Dividend 2016-17 and subsequent newspaper publication
30 May 2024
HIKAL LTD. - 524735 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for financial year ended March 31, 2024.
24 May 2024
HIKAL LTD. - 524735 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation of officials of the Company in the investors Conference organised by B and K Securities India.
24 May 2024
HIKAL LTD. - 524735 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Voting Results of Postal Ballot pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
24 May 2024
HIKAL LTD. - 524735 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting results of Postal Ballot through remote e-voting and Scrutinizer''s Report thereon
15 May 2024
HIKAL LTD. - 524735 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of earnings call held on May 9, 2024 for quarter and financial year ended March 31, 2024
09 May 2024
HIKAL LTD. - 524735 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Submission of audio recording of earnings conference call for the period ended Q4 FY24
09 May 2024
Hikal Results Earnings Call for Q4FY24
Conference Call with Hikal Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
09 May 2024
FY24 Annual Result Announced for Hikal Ltd.
Pharmaceuticals company Hikal announced FY24 results: Financial Highlights: Revenue of Rs 1,785 crore EBITDA stood at Rs 267 crore PAT stood at Rs 70 crores Recommended a final dividend of Rs 0.60 per share (30% of FV); Total dividend for FY24 stands at Rs 1.2 per share (60% of FV) Hikal’s long term credit rating is maintained at A+ by ICRA Commenting on the results, Jai Hiremath, Executive Chairman, Hikal said, “For the FY24, we achieved revenues of Rs 1,785 Crores as compared to Rs 2,023 Crores last year. FY24 was marred with several global macroeconomic pressures and depressed market conditions for the global chemical sector on account of inventory build up and overcapacity across the sector resulting in intense price competition from China predominantly in the Crop Protection market. Our Board of Directors has recommended a final dividend of Rs 0.60 per share (30%). Along with an interim dividend of Rs 0.60 per share (30%) declared in February 2024, the total dividend for FY24 stands at Rs 1.20 per share (60% of FV). For Q4FY24, our pharmaceutical business reported revenue growth of 26% to Rs 338 Cr and EBIT growth of 191% to Rs 54 Cr, on QoQ basis. In the API segment, we witnessed increased volume off-take based on higher demand from existing customers and from newer geographies. This coupled with stabilized raw material prices have supported us in maintaining our margin profile. In our CDMO segment we have received several RFP’s from both emerging pharma and global innovators, with several products progressing through the development stages. We have a healthy pipeline of projects in the early to mid-phase that is encouraging. During FY24, our API facility in Panoli, Gujarat, was audited by the US FDA, and the audit was concluded with ‘Zero’ 483 observations as a testament of our commitment to high standards of regulatory compliance. For Q4FY24, our crop protection business reported revenue of Rs 177 Cr and EBIT of Rs 14 Cr. Despite proactive cost improvement initiatives, the global crop protection industry continues to face significant headwinds, including subdued global demand due to inventory in the channel pipeline and intense price erosion from competitors primarily China as a result of large capacity which are under-utilized. We expect the market to stabilize post the end of this financial year and recovery to begin thereafter. In our animal health business, advancements in developing a portfolio of products under a long-term agreement with an innovator animal health company are proceeding well. During the third quarter, our new multipurpose animal health facility was commissioned at Panoli, Gujarat. Validation of several products is underway, and it is scheduled to be completed in the upcoming quarters. These validation batches mark the initial phase toward product registration and subsequent commercialization. Under our strategic transformation initiative - Pinnacle, we have taken substantial strides toward sustaining growth across our various businesses. We have gained momentum in supply chain derisking, developing differentiated capabilities, the acquisition of new customers and the building of a distinctive technology platform. As we navigate through the next stage of our strategic plan, our focus is directed more towards the front-end capitalizing on the opportunities to build a healthy pipeline for our businesses. Despite the current challenging global conditions, we anticipate a favorable shift in market dynamics over the mid to long term, and we remain focused in our strategy to deliver profitable, and sustainable growth across our businesses.” Result PDF
